Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?

What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

(2018) Christoph U. Correll et al.   World Psychiatry

A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia

(2017) Martin Harrow et al.   PSYCHIATRY RESEARCH

Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis

(2017) Regitze Sølling Wils et al.   SCHIZOPHRENIA RESEARCH

Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China

(2015) Mao-Sheng Ran et al.   BRITISH JOURNAL OF PSYCHIATRY

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

(2015) Masayuki Takase et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia

(2015) Tomotaka Suzuki et al.   PSYCHIATRY RESEARCH

Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study

(2014) C. Morgan et al.   PSYCHOLOGICAL MEDICINE

Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy

(2013) Lex Wunderink et al.   JAMA Psychiatry

Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study

(2011) J. Moilanen et al.   EUROPEAN PSYCHIATRY